|
HY-103332-10mg
|
MedChemexpress LLC
|
N-Arachidonylglycine [CAS 179113-91-8]
|
|
COVID-19-immunoregulation
|
|
|
HY-103332-100mg
|
MedChemexpress LLC
|
N-Arachidonylglycine [CAS 179113-91-8]
|
|
COVID-19-immunoregulation
|
|
|
HY-103332-25mg
|
MedChemexpress LLC
|
N-Arachidonylglycine [CAS 179113-91-8]
|
|
COVID-19-immunoregulation
|
|
|
HY-103332-5mg
|
MedChemexpress LLC
|
N-Arachidonylglycine [CAS 179113-91-8]
|
|
COVID-19-immunoregulation
|
|
|
HY-103332-50mg
|
MedChemexpress LLC
|
N-Arachidonylglycine [CAS 179113-91-8]
|
|
COVID-19-immunoregulation
|
|
|
HY-103637A-1mg
|
MedChemexpress LLC
|
Vimirogant (hydrochloride) [CAS 1802678-42-7]
|
|
COVID-19-immunoregulation
|
|
|
HY-103637A-10mg
|
MedChemexpress LLC
|
Vimirogant (hydrochloride) [CAS 1802678-42-7]
|
|
COVID-19-immunoregulation
|
|
|
HY-103637A-5mg
|
MedChemexpress LLC
|
Vimirogant (hydrochloride) [CAS 1802678-42-7]
|
|
COVID-19-immunoregulation
|
|
|
HY-109068-1mg
|
MedChemexpress LLC
|
Parsaclisib [CAS 1426698-88-5]
|
|
Cancer-Kinase/protease
|
|
|
HY-109068-10mg
|
MedChemexpress LLC
|
Parsaclisib [CAS 1426698-88-5]
|
|
Cancer-Kinase/protease
|
|
|
HY-109068-100mg
|
MedChemexpress LLC
|
Parsaclisib [CAS 1426698-88-5]
|
|
Cancer-Kinase/protease
|
|
|
HY-109068-25mg
|
MedChemexpress LLC
|
Parsaclisib [CAS 1426698-88-5]
|
|
Cancer-Kinase/protease
|
|
|
HY-109068-5mg
|
MedChemexpress LLC
|
Parsaclisib [CAS 1426698-88-5]
|
|
Cancer-Kinase/protease
|
|
|
HY-109068-50mg
|
MedChemexpress LLC
|
Parsaclisib [CAS 1426698-88-5]
|
|
Cancer-Kinase/protease
|
|
|
HY-109068A-10mg
|
MedChemexpress LLC
|
Parsaclisib (hydrochloride) [CAS 1995889-48-9]
|
|
Cancer-Kinase/protease
|
|
|
HY-109068A-100mg
|
MedChemexpress LLC
|
Parsaclisib (hydrochloride) [CAS 1995889-48-9]
|
|
Cancer-Kinase/protease
|
|
|
HY-109068A-25mg
|
MedChemexpress LLC
|
Parsaclisib (hydrochloride) [CAS 1995889-48-9]
|
|
Cancer-Kinase/protease
|
|
|
HY-109068A-5mg
|
MedChemexpress LLC
|
Parsaclisib (hydrochloride) [CAS 1995889-48-9]
|
|
Cancer-Kinase/protease
|
|
|
HY-109068A-50mg
|
MedChemexpress LLC
|
Parsaclisib (hydrochloride) [CAS 1995889-48-9]
|
|
Cancer-Kinase/protease
|
|
|
HY-111226-1mg
|
MedChemexpress LLC
|
GSK5182 [CAS 877387-37-6]
|
|
Cancer-programmed cell death
|
|
|
HY-111226-10mg
|
MedChemexpress LLC
|
GSK5182 [CAS 877387-37-6]
|
|
Cancer-programmed cell death
|
|
|
HY-111226-100mg
|
MedChemexpress LLC
|
GSK5182 [CAS 877387-37-6]
|
|
Cancer-programmed cell death
|
|
|
HY-111226-25mg
|
MedChemexpress LLC
|
GSK5182 [CAS 877387-37-6]
|
|
Cancer-programmed cell death
|
|
|
HY-111226-5mg
|
MedChemexpress LLC
|
GSK5182 [CAS 877387-37-6]
|
|
Cancer-programmed cell death
|
|
|
HY-111226-50mg
|
MedChemexpress LLC
|
GSK5182 [CAS 877387-37-6]
|
|
Cancer-programmed cell death
|
|
